Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||1.44%||30.24||14.1%||$177.94m|
|HZNP||Horizon Therapeutics Plc||-0.19%||91.45||5.5%||$174.64m|
|GWPH||GW Pharmaceuticals Plc||0.17%||218.36||6.1%||$132.57m|
|BHC||Bausch Health Cos., Inc.||1.44%||30.24||0.0%||$123.31m|
|UTHR||United Therapeutics Corp.||1.75%||202.78||14.1%||$98.97m|
|JAZZ||Jazz Pharmaceuticals Plc||1.87%||166.37||2.3%||$88.00m|
|SAVA||Cassava Sciences, Inc.||-1.00%||35.67||0.0%||$69.79m|
|SAGE||SAGE Therapeutics, Inc.||5.19%||75.67||7.6%||$37.98m|
|PRGO||Perrigo Co. Plc||0.65%||40.41||6.9%||$37.14m|
|AMRN||Amarin Corp. Plc||0.59%||5.11||1.5%||$28.81m|
|PCRX||Pacira Biosciences, Inc.||1.71%||69.43||9.9%||$26.96m|
|ICPT||Intercept Pharmaceuticals, Inc.||1.13%||21.41||16.8%||$21.61m|
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.